{"transactions":[{"id":767912,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T00:11:23.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":54933,"price":1.8999,"value":104367.2067,"ownership":{"direct":true},"balance_after":3364883,"source":{"system":"sec-edgar","filing":"0001104659-26-065311","document":"tm2615429-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926065311/tm2615429-1_4seq1.xml","form_type":"4"}},{"id":767911,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T00:11:23.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":18849,"price":1.8,"value":33928.2,"ownership":{"direct":true},"balance_after":3309950,"source":{"system":"sec-edgar","filing":"0001104659-26-065311","document":"tm2615429-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926065311/tm2615429-1_4seq1.xml","form_type":"4"}},{"id":767910,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T00:11:23.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":2562,"price":1.75,"value":4483.5,"ownership":{"direct":true},"balance_after":3291101,"source":{"system":"sec-edgar","filing":"0001104659-26-065311","document":"tm2615429-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926065311/tm2615429-1_4seq1.xml","form_type":"4"}},{"id":816275,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T21:06:28.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":713800,"price":2.1,"value":1498980.0,"ownership":{"direct":true},"balance_after":3288539,"source":{"system":"sec-edgar","filing":"0001104659-26-039675","document":"tm2611081-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926039675/tm2611081-1_4seq1.xml","form_type":"4"}},{"id":977563,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T01:05:14.000Z","date":"2025-12-08","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":4.24,"value":63600.0,"ownership":{"direct":true},"balance_after":2574739,"source":{"system":"sec-edgar","filing":"0001104659-25-119407","document":"tm2533031-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925119407/tm2533031-1_4seq1.xml","form_type":"4"}},{"id":977562,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T01:05:14.000Z","date":"2025-12-08","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":4.3398,"value":130194.0,"ownership":{"direct":true},"balance_after":2559739,"source":{"system":"sec-edgar","filing":"0001104659-25-119407","document":"tm2533031-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925119407/tm2533031-1_4seq1.xml","form_type":"4"}},{"id":988629,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:59:54.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":28096,"price":4.15,"value":116598.4,"ownership":{"direct":true},"balance_after":2529739,"source":{"system":"sec-edgar","filing":"0001104659-25-116084","document":"tm2532217-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925116084/tm2532217-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-11-24"}},{"id":988628,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:59:54.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":415,"price":4.14,"value":1718.1,"ownership":{"direct":true},"balance_after":2501643,"source":{"system":"sec-edgar","filing":"0001104659-25-116084","document":"tm2532217-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925116084/tm2532217-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-11-24"}},{"id":988627,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:59:54.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":9200,"price":3.85,"value":35420.0,"ownership":{"direct":true},"balance_after":2501228,"source":{"system":"sec-edgar","filing":"0001104659-25-116084","document":"tm2532217-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925116084/tm2532217-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-11-24"}},{"id":988626,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:59:54.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":1489,"price":4.13,"value":6149.57,"ownership":{"direct":true},"balance_after":2492028,"source":{"system":"sec-edgar","filing":"0001104659-25-116084","document":"tm2532217-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925116084/tm2532217-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-11-24"}},{"id":988623,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:26:46.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":28096,"price":4.15,"value":116598.4,"ownership":{"direct":true},"balance_after":2519739,"source":{"system":"sec-edgar","filing":"0001104659-25-115801","document":"tm2532176-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115801/tm2532176-1_4seq1.xml","form_type":"4"}},{"id":988622,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:26:46.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":415,"price":4.14,"value":1718.1,"ownership":{"direct":true},"balance_after":2491643,"source":{"system":"sec-edgar","filing":"0001104659-25-115801","document":"tm2532176-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115801/tm2532176-1_4seq1.xml","form_type":"4"}},{"id":988621,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:26:46.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":9200,"price":3.85,"value":35420.0,"ownership":{"direct":true},"balance_after":2491228,"source":{"system":"sec-edgar","filing":"0001104659-25-115801","document":"tm2532176-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115801/tm2532176-1_4seq1.xml","form_type":"4"}},{"id":988620,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:26:46.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":1489,"price":4.13,"value":6149.57,"ownership":{"direct":true},"balance_after":2482028,"source":{"system":"sec-edgar","filing":"0001104659-25-115801","document":"tm2532176-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115801/tm2532176-1_4seq1.xml","form_type":"4"}},{"id":991251,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T00:57:45.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.5,"value":35000.0,"ownership":{"direct":true},"balance_after":2490539,"source":{"system":"sec-edgar","filing":"0001104659-25-115090","document":"tm2531989-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115090/tm2531989-1_4seq1.xml","form_type":"4"}},{"id":991250,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T00:57:45.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.49,"value":34900.0,"ownership":{"direct":true},"balance_after":2480539,"source":{"system":"sec-edgar","filing":"0001104659-25-115090","document":"tm2531989-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115090/tm2531989-1_4seq1.xml","form_type":"4"}},{"id":995640,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T12:44:02.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.11,"value":31650.0,"ownership":{"direct":true},"balance_after":2470539,"source":{"system":"sec-edgar","filing":"0001104659-25-113459","document":"tm2531527-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925113459/tm2531527-1_4seq1.xml","form_type":"4"}},{"id":1001951,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-12T14:19:04.000Z","date":"2025-10-28","kind":"purchase","planned":false,"acquired":true,"shares":97561,"price":2.05,"value":200000.05,"ownership":{"direct":true},"balance_after":1212020,"source":{"system":"sec-edgar","filing":"0001104659-25-109906","document":"tm2527472-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925109906/tm2527472-3_4seq1.xml","form_type":"4"}},{"id":1001950,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T14:18:23.000Z","date":"2025-10-28","kind":"purchase","planned":false,"acquired":true,"shares":975610,"price":2.05,"value":2000000.5,"ownership":{"direct":true},"balance_after":2455539,"source":{"system":"sec-edgar","filing":"0001104659-25-109905","document":"tm2527472-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925109905/tm2527472-2_4seq1.xml","form_type":"4"}},{"id":1001949,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2025-11-12T14:17:18.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":7142,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.14,"exercise_date":"2016-09-18","expiration_date":"2025-09-18","underlying":"Common Stock","underlying_shares":7142},"source":{"system":"sec-edgar","filing":"0001104659-25-109904","document":"tm2527472-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925109904/tm2527472-1_4seq1.xml","form_type":"4"}},{"id":1001948,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T14:17:18.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":7142,"price":0.14,"value":999.88,"ownership":{"direct":true},"balance_after":13709,"source":{"system":"sec-edgar","filing":"0001104659-25-109904","document":"tm2527472-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925109904/tm2527472-1_4seq1.xml","form_type":"4"}},{"id":1049506,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T20:41:47.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.3,"value":11500.0,"ownership":{"direct":true},"balance_after":1479929,"source":{"system":"sec-edgar","filing":"0001104659-25-087077","document":"tm2525175-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925087077/tm2525175-1_4seq1.xml","form_type":"4"}},{"id":1049505,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T20:41:47.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.29,"value":11450.0,"ownership":{"direct":true},"balance_after":1474929,"source":{"system":"sec-edgar","filing":"0001104659-25-087077","document":"tm2525175-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925087077/tm2525175-1_4seq1.xml","form_type":"4"}},{"id":1049504,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T20:41:47.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.28,"value":11400.0,"ownership":{"direct":true},"balance_after":1469929,"source":{"system":"sec-edgar","filing":"0001104659-25-087077","document":"tm2525175-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925087077/tm2525175-1_4seq1.xml","form_type":"4"}},{"id":1060203,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:20:14.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":1100,"price":2.57,"value":2827.0,"ownership":{"direct":true},"balance_after":1464929,"source":{"system":"sec-edgar","filing":"0001104659-25-080981","document":"tm2523925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925080981/tm2523925-1_4seq1.xml","form_type":"4"}},{"id":1060202,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:20:14.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":5545,"price":2.58,"value":14306.1,"ownership":{"direct":true},"balance_after":1463829,"source":{"system":"sec-edgar","filing":"0001104659-25-080981","document":"tm2523925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925080981/tm2523925-1_4seq1.xml","form_type":"4"}},{"id":1060201,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:20:14.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":5283,"price":2.59,"value":13682.97,"ownership":{"direct":true},"balance_after":1458284,"source":{"system":"sec-edgar","filing":"0001104659-25-080981","document":"tm2523925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925080981/tm2523925-1_4seq1.xml","form_type":"4"}},{"id":1060200,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:20:14.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":6717,"price":2.6,"value":17464.2,"ownership":{"direct":true},"balance_after":1453001,"source":{"system":"sec-edgar","filing":"0001104659-25-080981","document":"tm2523925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925080981/tm2523925-1_4seq1.xml","form_type":"4"}},{"id":1106664,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78341,"kind":"person","name":"Walsh Andrew","position":1,"cik":"0002068849","reported_name":"Walsh Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-06-18T16:05:16.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":500,"price":2.9,"value":1450.0,"ownership":{"direct":true},"balance_after":500,"source":{"system":"sec-edgar","filing":"0001104659-25-060632","document":"tm2518255-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2068849/000110465925060632/tm2518255-1_4seq1.xml","form_type":"4"}},{"id":1109719,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:28:52.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":1,"price":2.83,"value":2.83,"ownership":{"direct":true},"balance_after":1446284,"source":{"system":"sec-edgar","filing":"0001104659-25-059897","document":"tm2518124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925059897/tm2518124-1_4seq1.xml","form_type":"4"}},{"id":1109718,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:28:52.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":2.8,"value":70000.0,"ownership":{"direct":true},"balance_after":1446283,"source":{"system":"sec-edgar","filing":"0001104659-25-059897","document":"tm2518124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925059897/tm2518124-1_4seq1.xml","form_type":"4"}},{"id":1114859,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T20:01:14.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":2.95,"value":5900.0,"ownership":{"direct":true},"balance_after":9305,"source":{"system":"sec-edgar","filing":"0001104659-25-058521","document":"tm2517636-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925058521/tm2517636-1_4seq1.xml","form_type":"4"}},{"id":1121247,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-05T10:00:15.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":46000,"price":3.37,"value":155020.0,"ownership":{"direct":true},"balance_after":1114459,"source":{"system":"sec-edgar","filing":"0001104659-25-056578","document":"tm2517204-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925056578/tm2517204-1_4seq1.xml","form_type":"4"}},{"id":1127586,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T20:35:53.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.43,"value":12150.0,"ownership":{"direct":true},"balance_after":1421283,"source":{"system":"sec-edgar","filing":"0001104659-25-055487","document":"tm2516868-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925055487/tm2516868-1_4seq1.xml","form_type":"4"}},{"id":1459849,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:18:10.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The stock option was granted in consideration for consulting services that reporting person will perform for the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option shall vest in quarterly increments, based upon the services performed by the reporting person under the related Consulting Agreement."}],"balance_after":20000,"derivative":{"exercise_price":5.27,"expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-24-077836","document":"tm2417696-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077836/tm2417696-5_4seq1.xml","form_type":"4"}},{"id":1459848,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:18:10.000Z","date":"2023-11-27","kind":"grant","planned":false,"acquired":true,"shares":2146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The stock option was granted in consideration for consulting services that reporting person will perform for the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":2146,"derivative":{"exercise_price":7.39,"expiration_date":"2033-11-27","underlying":"Common Stock","underlying_shares":2146},"source":{"system":"sec-edgar","filing":"0001104659-24-077836","document":"tm2417696-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077836/tm2417696-5_4seq1.xml","form_type":"4"}},{"id":1459847,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:18:10.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":26200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. (\"the Company\") approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":26200,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":26200},"source":{"system":"sec-edgar","filing":"0001104659-24-077836","document":"tm2417696-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077836/tm2417696-5_4seq1.xml","form_type":"4"}},{"id":1459846,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:17:22.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":29600,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001104659-24-077835","document":"tm2417696-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077835/tm2417696-4_4seq1.xml","form_type":"4"}},{"id":1459845,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:16:55.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":108800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The stock option was granted in lieu of cash payment for 2023 fiscal year bonus. 100% of the stock option grant listed was also contingent upon the aforementioned amendment to the 2019 Equity Incentive Plan to increase the number of issuable shares from 2,000,000 to 3,000,000. It would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option shall vest immediately."}],"balance_after":108800,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":108800},"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459844,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:16:55.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock option will vest in eight consecutive quarterly installments of 31,500 shares each on the 17th day of February, May, August and November of each year, continuing through November 17, 2025."}],"balance_after":252000,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":252000},"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459843,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T21:16:55.000Z","date":"2024-03-31","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents charitable gifts donated by the reporting person. No proceeds were received by the reporting person."}],"balance_after":1068459,"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459842,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T21:16:55.000Z","date":"2024-03-31","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents charitable gifts donated by the reporting person. No proceeds were received by the reporting person."}],"balance_after":1078459,"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459841,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T21:16:55.000Z","date":"2024-03-28","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents charitable gifts donated by the reporting person. No proceeds were received by the reporting person."}],"balance_after":1088459,"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459840,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:16:18.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":29600,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001104659-24-077833","document":"tm2417696-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077833/tm2417696-2_4seq1.xml","form_type":"4"}},{"id":1459839,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:15:43.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":26200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":26200,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":26200},"source":{"system":"sec-edgar","filing":"0001104659-24-077831","document":"tm2417696-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077831/tm2417696-1_4seq1.xml","form_type":"4"}},{"id":1731166,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:27:49.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":1990,"price":6.1,"value":12139.0,"ownership":{"direct":true},"balance_after":61167,"source":{"system":"sec-edgar","filing":"0001104659-23-120769","document":"tm2331305-10_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120769/tm2331305-10_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1731161,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:24:29.000Z","date":"2023-11-20","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed solely to reverse the previously reported purchase on the original form 4 filed on November 21, 2023 (the \"Original Form 4\"). Such purchase was rescinded by the registrant and the reporting person on November 22, 2023."}],"balance_after":7305,"source":{"system":"sec-edgar","filing":"0001104659-23-120765","document":"tm2331305-12_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120765/tm2331305-12_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1731160,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:24:21.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":163880,"price":6.1,"value":999668.0,"ownership":{"direct":false,"nature":"The 2018 Jane and Michael Hoffman Descendants Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares."}],"balance_after":223357,"source":{"system":"sec-edgar","filing":"0001104659-23-120764","document":"tm2331305-9_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120764/tm2331305-9_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1731158,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-22T21:23:15.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":40970,"price":6.1,"value":249917.0,"ownership":{"direct":true},"balance_after":1098459,"source":{"system":"sec-edgar","filing":"0001104659-23-120762","document":"tm2331305-11_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120762/tm2331305-11_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1731157,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-22T21:21:13.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":820,"price":6.1,"value":5002.0,"ownership":{"direct":true},"balance_after":1820,"source":{"system":"sec-edgar","filing":"0001104659-23-120760","document":"tm2331305d8_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120760/tm2331305d8_4a.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1731159,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:14:47.000Z","date":"2023-11-20","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed solely to reverse the previously reported purchase on the original form 4 filed on November 21, 2023 (the \"Original Form 4\"). Such purchase was rescinded by the registrant and the reporting person on November 22, 2023."}],"balance_after":6567,"source":{"system":"sec-edgar","filing":"0001104659-23-120749","document":"tm2331305-7_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120749/tm2331305-7_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1732549,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T19:33:45.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":824,"price":6.07,"value":5001.68,"ownership":{"direct":true},"balance_after":8129,"source":{"system":"sec-edgar","filing":"0001104659-23-120305","document":"tm2331305d6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120305/tm2331305d6_4seq1.xml","form_type":"4"}},{"id":1732548,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T19:32:26.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":164745,"price":6.07,"value":1000002.15,"ownership":{"direct":false,"nature":"The 2018 Jane and Michael Hoffman Descendants Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares."}],"balance_after":224222,"source":{"system":"sec-edgar","filing":"0001104659-23-120304","document":"tm2331305-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120304/tm2331305-5_4seq1.xml","form_type":"4"}},{"id":1732547,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T19:31:38.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":6.07,"value":12140.0,"ownership":{"direct":true},"balance_after":61177,"source":{"system":"sec-edgar","filing":"0001104659-23-120303","document":"tm2331305-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120303/tm2331305-4_4seq1.xml","form_type":"4"}},{"id":1732546,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-21T19:30:35.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":41186,"price":6.07,"value":249999.02,"ownership":{"direct":true},"balance_after":1098675,"source":{"system":"sec-edgar","filing":"0001104659-23-120302","document":"tm2331305-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120302/tm2331305-3_4seq1.xml","form_type":"4"}},{"id":1732545,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T19:29:31.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":824,"price":6.07,"value":5001.68,"ownership":{"direct":true},"balance_after":1824,"source":{"system":"sec-edgar","filing":"0001104659-23-120301","document":"tm2331305-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120301/tm2331305-2_4seq1.xml","form_type":"4"}},{"id":1732544,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T19:27:58.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":6.07,"value":6070.0,"ownership":{"direct":true},"balance_after":7567,"source":{"system":"sec-edgar","filing":"0001104659-23-120299","document":"tm2331305-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120299/tm2331305-1_4seq1.xml","form_type":"4"}},{"id":1913305,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-26T20:34:01.000Z","date":"2023-04-24","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1057489,"source":{"system":"sec-edgar","filing":"0001104659-23-050393","document":"tm2313853-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923050393/tm2313853-1_4seq1.xml","form_type":"4"}},{"id":1921743,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T01:14:02.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":12.61,"value":37830.0,"ownership":{"direct":true},"balance_after":59177,"source":{"system":"sec-edgar","filing":"0001104659-23-044209","document":"tm2312464-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044209/tm2312464-6_4seq1.xml","form_type":"4"}},{"id":1921742,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T01:11:11.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":500,"price":12.61,"value":6305.0,"ownership":{"direct":true},"balance_after":6567,"source":{"system":"sec-edgar","filing":"0001104659-23-044208","document":"tm2312464-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044208/tm2312464-5_4seq1.xml","form_type":"4"}},{"id":1921741,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-12T01:08:59.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":12.61,"value":12610.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001104659-23-044206","document":"tm2312464-4_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044206/tm2312464-4_4seq.xml","form_type":"4"}},{"id":1921740,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T01:06:18.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":59477,"price":12.61,"value":750004.97,"ownership":{"direct":false,"nature":"The 2018 Jane and Michael Hoffman Descendants Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares."}],"balance_after":59477,"source":{"system":"sec-edgar","filing":"0001104659-23-044204","document":"tm2312464-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044204/tm2312464-3_4seq1.xml","form_type":"4"}},{"id":1921739,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T01:05:04.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":476,"price":12.61,"value":6002.36,"ownership":{"direct":true},"balance_after":7305,"source":{"system":"sec-edgar","filing":"0001104659-23-044203","document":"tm2312464-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044203/tm2312464-2_4seq1.xml","form_type":"4"}},{"id":1921738,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-12T01:03:33.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":12.61,"value":252200.0,"ownership":{"direct":true},"balance_after":1060489,"source":{"system":"sec-edgar","filing":"0001104659-23-044202","document":"tm2312464-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044202/tm2312464-1_4seq1.xml","form_type":"4"}},{"id":2026470,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-08T22:11:34.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":52755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares underlying the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.14,"expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":52755},"source":{"system":"sec-edgar","filing":"0001104659-23-014610","document":"tm231947-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923014610/tm231947-2_4seq1.xml","form_type":"4"}},{"id":2026469,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-08T22:11:34.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":52755,"price":0.14,"value":7385.7,"ownership":{"direct":true},"balance_after":1040489,"source":{"system":"sec-edgar","filing":"0001104659-23-014610","document":"tm231947-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923014610/tm231947-2_4seq1.xml","form_type":"4"}},{"id":2049602,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:43:08.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":21312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 2,664 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":21312,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":21312},"source":{"system":"sec-edgar","filing":"0001104659-23-005481","document":"tm234043-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005481/tm234043-6_4seq1.xml","form_type":"4"}},{"id":2049601,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:42:04.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":7672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 1,918 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":7672,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":7672},"source":{"system":"sec-edgar","filing":"0001104659-23-005480","document":"tm234043-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005480/tm234043-5_4seq1.xml","form_type":"4"}},{"id":2049600,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:40:59.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":5967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":5967,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":5967},"source":{"system":"sec-edgar","filing":"0001104659-23-005478","document":"tm234043-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005478/tm234043-4_4seq1.xml","form_type":"4"}},{"id":2049599,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:39:35.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":5967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":5967,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":5967},"source":{"system":"sec-edgar","filing":"0001104659-23-005477","document":"tm234043-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005477/tm234043-3_4seq1.xml","form_type":"4"}},{"id":2049669,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:38:36.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":6820,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001104659-23-005476","document":"tm234043-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005476/tm234043-2_4seq1.xml","form_type":"4"}},{"id":2049645,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:37:35.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":5967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":5967,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":5967},"source":{"system":"sec-edgar","filing":"0001104659-23-005475","document":"tm234043-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005475/tm234043-1_4seq1.xml","form_type":"4"}},{"id":2169942,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-01T00:14:11.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on August 29, 2023 and the remaining two-thirds will vest in eight consecutive quarterly installments beginning the fifteenth month after August 29, 2022, and will vest in full upon a Change of Control (as defined in the Company's 2019 Equity Incentive Plan), with vesting conditioned on continued employment on the applicable vesting dates."}],"balance_after":120000,"derivative":{"exercise_price":11.55,"expiration_date":"2032-08-29","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001104659-22-096653","document":"tm2224852-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922096653/tm2224852-2_4seq1.xml","form_type":"4"}},{"id":2433720,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-19T02:08:43.000Z","date":"2022-01-14","kind":"exercise","acquired":false,"shares":32959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares underlying the option are fully vested and exercisable."}],"balance_after":52755,"derivative":{"exercise_price":0.14,"expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":32959},"source":{"system":"sec-edgar","filing":"0001104659-22-005059","document":"tm221949-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005059/tm221949-7_4seq1.xml","form_type":"4"}},{"id":2433719,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:08:43.000Z","date":"2022-01-14","kind":"exercise","acquired":true,"shares":32959,"price":0.14,"value":4614.26,"ownership":{"direct":true},"balance_after":987734,"source":{"system":"sec-edgar","filing":"0001104659-22-005059","document":"tm221949-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005059/tm221949-7_4seq1.xml","form_type":"4"}},{"id":2433707,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2021-12-20","kind":"gift","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":954775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2433706,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2021-07-01","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":974775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2433705,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2021-07-01","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":975775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2433704,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2020-07-15","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Charitable gift that was not previously reported in a Form 5 for the fiscal year ended December 31, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":976775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2433703,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2020-04-27","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Charitable gift that was not previously reported in a Form 5 for the fiscal year ended December 31, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":986775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2443825,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:44:12.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001104659-22-001644","document":"tm221949-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001644/tm221949-6_4seq1.xml","form_type":"4"}},{"id":2443824,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":131614,"kind":"person","name":"McGroarty Jeffrey Brian","position":1,"cik":"0001563273","reported_name":"McGroarty Jeffrey Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:43:28.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 3,500 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":28000,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001104659-22-001643","document":"tm221949-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001643/tm221949-5_4seq1.xml","form_type":"4"}},{"id":2443823,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":78621,"kind":"person","name":"McCarthy Reid","position":1,"cik":"0001857733","reported_name":"McCarthy Reid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:42:52.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001104659-22-001642","document":"tm221949-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001642/tm221949-4_4seq1.xml","form_type":"4"}},{"id":2443822,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:42:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":19894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in two equal installments of 9,947 shares on March 31, 2022 and March 31, 2023."}],"balance_after":19894,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":19894},"source":{"system":"sec-edgar","filing":"0001104659-22-001640","document":"tm221949-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001640/tm221949-3_4seq1.xml","form_type":"4"}},{"id":2443821,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:42:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":83400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 10,425 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":83400,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":83400},"source":{"system":"sec-edgar","filing":"0001104659-22-001640","document":"tm221949-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001640/tm221949-3_4seq1.xml","form_type":"4"}},{"id":2443820,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":7142,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.25,"exercise_date":"2018-04-06","expiration_date":"2028-04-06","underlying":"Common Stock","underlying_shares":7142},"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443819,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.39,"exercise_date":"2020-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443818,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest in eight consecutive quarterly installments of 1,125 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":9000,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443817,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":90,"price":19.78,"value":1780.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects 90 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $0.25 per share to fund the cashless exercise of 7,142 options."}],"balance_after":1416283,"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443816,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":7142,"price":0.25,"value":1785.5,"ownership":{"direct":true},"balance_after":1416373,"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443815,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":6658,"price":19.78,"value":131695.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 6,658 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $4.39 per share to fund the cashless exercise of 30,000 options."}],"balance_after":1409231,"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443814,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":30000,"price":4.39,"value":131700.0,"ownership":{"direct":true},"balance_after":1415889,"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443813,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:40:57.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001104659-22-001637","document":"tm221949-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001637/tm221949-1_4seq1.xml","form_type":"4"}},{"id":2480598,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":131614,"kind":"person","name":"McGroarty Jeffrey Brian","position":1,"cik":"0001563273","reported_name":"McGroarty Jeffrey Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:01:36.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":165199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest in two installments: (i) the first installment of 82,600 shares on March 31, 2022 and (ii) a second and final installment of 82,599 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date."}],"balance_after":165199,"derivative":{"exercise_price":20.97,"expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":165199},"source":{"system":"sec-edgar","filing":"0001104659-21-147676","document":"tm2134914d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921147676/tm2134914d2_4seq1.xml","form_type":"4"}},{"id":2480597,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":131614,"kind":"person","name":"McGroarty Jeffrey Brian","position":1,"cik":"0001563273","reported_name":"McGroarty Jeffrey Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:01:36.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":30396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is 100% vested."}],"balance_after":30396,"derivative":{"exercise_price":20.97,"exercise_date":"2021-12-06","expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":30396},"source":{"system":"sec-edgar","filing":"0001104659-21-147676","document":"tm2134914d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921147676/tm2134914d2_4seq1.xml","form_type":"4"}},{"id":2480596,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:00:47.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":145305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest in two installments: (i) the first installment of 72,653 shares on March 31, 2022 and (ii) a second and final installment of 72,652 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date."}],"balance_after":145305,"derivative":{"exercise_price":20.97,"expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":145305},"source":{"system":"sec-edgar","filing":"0001104659-21-147673","document":"tm2134914-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921147673/tm2134914-1_4seq1.xml","form_type":"4"}},{"id":2480595,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:00:47.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":112995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is 100% vested."}],"balance_after":112995,"derivative":{"exercise_price":20.97,"exercise_date":"2021-12-06","expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":112995},"source":{"system":"sec-edgar","filing":"0001104659-21-147673","document":"tm2134914-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921147673/tm2134914-1_4seq1.xml","form_type":"4"}},{"id":2543371,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":73316,"kind":"person","name":"Bruck Claudine","position":1,"cik":"0001733680","reported_name":"Bruck Claudine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T20:03:10.000Z","date":"2021-10-11","kind":"purchase","acquired":true,"shares":181,"price":27.66,"value":5006.46,"ownership":{"direct":true},"balance_after":6067,"source":{"system":"sec-edgar","filing":"0001415889-21-004864","document":"form4-10132021_011056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000141588921004864/form4-10132021_011056.xml","form_type":"4"}},{"id":2543370,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":89185,"kind":"person","name":"White Mark K.","position":1,"cik":"0001786183","reported_name":"White Mark K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T20:02:04.000Z","date":"2021-10-12","kind":"purchase","acquired":true,"shares":5000,"price":27.4,"value":137000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.25 to $27.55, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":56177,"source":{"system":"sec-edgar","filing":"0001415889-21-004863","document":"form4-10132021_011054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000141588921004863/form4-10132021_011054.xml","form_type":"4"}},{"id":2543359,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-10-13T20:00:52.000Z","date":"2021-10-11","kind":"purchase","acquired":true,"shares":18000,"price":27.61,"value":496980.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.58 to $27.64, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":976775,"source":{"system":"sec-edgar","filing":"0001415889-21-004862","document":"form4-10132021_011036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000141588921004862/form4-10132021_011036.xml","form_type":"4"}}],"next_cursor":"2021-10-13T20:00:52.000000Z,2543359"}